Medications for Acute Coronary Syndromes
KEYWORDS: patients, orally, risk, heparin, pci, day, used, hours, bleeding, given, nitroglycerin, therapy, coronary, use, acs

PCI or 4000 units; bolus) given patients > 75 years when alteplase, reteplase, receiving tenecteplase or tenecteplase is started, then followed by 12 units/kg/hour (maximum, 1000 units/hour) for 48 hours or until PCI is complete Anticoagulants: Vitamin K inhibitor Warfarin Oral dose adjusted to Recommended for maintain INR of 2–3 primary prevention in patients at high risk of systemic emboli (ie, with atrial fibrillation, mechanical heart valves, venous thromboembolism, hypercoagulable disorders, or LV thrombus) Medication Dosage Use May be useful for primary prevention in patients with STEMI and anterior wall akinesis or dyskinesis if risk of bleeding is low Reasonable for patients with asymptomatic mural thrombus Antiplatelet agents For stable angina†: 75 or 81 mg orally once a day (enteric-coated) All patients with CAD For ACS: 160–325 mg unless aspirin is not orally chewed (not enteric- Aspirin tolerated or is coated) on arrival at contraindicated; used emergency department long-term and once a day thereafter during hospitalization and 81 mg§ orally once a day long-term after discharge Used with aspirin or, in patients who cannot tolerate aspirin, alone For elective PCI, maintenance therapy 75 mg orally once a day required for at least 1 For patients undergoing month for bare-metal PCI:
